McKesson has reported earnings today — the July 22 print the prior note flagged — and the market's reaction now sets the tone for what comes next, with the August 5 date already confirmed as the next scheduled event.
The clearest shift this week is in options sentiment, and it runs in an unusual direction for an earnings aftermath. The put/call ratio has dropped to 0.53, more than two standard deviations below its 20-day average of 0.58 — the most call-heavy reading in the past year, with the 52-week low for PCR at 0.50. That marks a meaningful tilt toward bullish positioning. Traders are not reaching for downside protection; they are leaning into upside. The move is notable given that the prior note described options as "unbothered," with a z-score near zero. Something has changed — the PCR has compressed sharply in just two sessions.
Short interest tells a more cautious sub-story, though not an alarming one. It has crept up about 5% on the week to 3.5% of the free float — reversing a brief mid-week dip — but that reading remains well below the June peak near 4.8%. The borrow market continues to impose no friction whatsoever: cost to borrow is running at 0.53%, and availability is extraordinarily loose at over 6,000% of short interest. For every share currently borrowed short, more than 60 sit available in the lending pool. There is no squeeze dynamic, no urgency in the short base, and no sign that bears are pressing a conviction view.
The Street remains broadly constructive, though targets have drifted lower all year. TD Cowen trimmed its target to $989 from $1,012 this morning while holding its Buy rating — a modest haircut that keeps it well above the current $828 price. The consensus mean sits near $941, implying roughly 14% upside from current levels. Most of the active ratings are Buys or Overweights, with Wells Fargo the outlier at Equal-Weight and an $812 target that is now effectively at-the-money. Valuation multiples have moved modestly: the forward P/E has expanded about 1.6 turns over the past 30 days to 17.4x, reflecting the stock's 10% monthly gain, while EV/EBITDA has edged slightly lower. The stock's EPS surprise factor score ranks in the 76th percentile — McKesson has a consistent track record of beating estimates — though the 12-month forward EPS growth score, at the 17th percentile, flags that expectations for acceleration remain modest.
Insider activity is worth a brief note, though the pattern is not alarming in isolation. CEO Brian Scott Tyler sold approximately $6.7 million in shares on July 7 and a similar amount in mid-June, continuing a steady cadence of disposals. The 90-day net insider position is a sale of roughly $27.5 million. These are programmatic in tone — regular lot sizes, routine cadence — and carry low trade-significance scores, but the one-way direction from the c-suite across multiple officers is a data point worth keeping in frame alongside the bullish options tilt.
Among close peers, CAH was up 0.6% on the day while COR was fractionally lower, both roughly tracking McKesson's own -0.3% session. ENSG added 2.5% on the week. The relative stability across the group suggests no sector-level shock from today's print, which itself would align with the muted options setup going in.
The setup heading into August 5 — whether that is a revised reporting date or a separate catalyst — is one where call buyers are in control, short sellers are not pressing, and the Street consensus points significantly higher than the current price. What to watch is whether the call-heavy positioning holds or fades as more clarity emerges on the July 22 result, and whether analyst targets begin to converge toward — or away from — the $940 mean.
See the live data behind this article on ORTEX.
Open MCK on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
